Martin Shkreli, disgraced pharma CEO, to face congressional hearing

A U.S. congressional committee is demanding former drug executive Martin Shkreli appear at a hearing on drug prices to testify about his former company's decision to raise the price of a lifesaving drug by more than 5,000 per cent, congressional aides said on Wednesday.